← back to search

Christopher Steer

Albury Wodonga Health ·
Area of research
Geriatrics and Gerontology · Oncology
Research interest
Research interests include Frailty in Older Adults, Cancer survivorship and care, Ovarian cancer diagnosis and treatment, and Palliative Care and End-of-Life Issues.
h-index
31
citations
4,340
works
173
NIH funding
primary concept
Medicine
email

Recent publications

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Oncology 2024cited by 102position: middledoi
The effect of comprehensive geriatric assessment on care received, treatment completion, toxicity, cancer-related and geriatric assessment outcomes, and quality of life for older adults receiving systemic anti-cancer treatment: A systematic review
Journal of Geriatric Oncology 2023cited by 46position: middledoi
Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci
JNCI Journal of the National Cancer Institute 2022cited by 13position: middledoi
Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial
Annals of Oncology 2021cited by 111position: middledoi
Practical Considerations for Treating Patients With Cancer in the COVID-19 Pandemic
JCO Oncology Practice 2020cited by 67position: middledoi
Multidisciplinary development of the Geriatric Core Dataset for clinical research in older patients with cancer: A French initiative with international survey
European Journal of Cancer 2018cited by 68position: middledoi
Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations
Annals of Oncology 2014cited by 769position: middledoi
Immigrants' perceptions of the quality of their cancer care: an Australian comparative study, identifying potentially modifiable factors
Annals of Oncology 2014cited by 90position: middledoi
Randomized Phase III Study of Erlotinib Versus Observation in Patients With No Evidence of Disease Progression After First-Line Platin-Based Chemotherapy for Ovarian Carcinoma: A European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup Study
Journal of Clinical Oncology 2013cited by 113position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Narayan Karanth · Niagara Health System2 papers (2014–2020)Winston Liauw · St George Hospital1 papers (2014–2014)Umberto Basso · Marche Polytechnic University1 papers (2014–2014)Nick Pavlakis · University of Sydney1 papers (2020–2020)Marion Harris · Monash Health1 papers (2014–2014) · 1 papers (2014–2014)Prunella Blinman · Concord Repatriation General Hospital1 papers (2023–2023)Nicoletta Colombo · University of Milan1 papers (2013–2013)Shengjie Dong · Yantaishan Hospital1 papers (2014–2014)Hervé Curé · KU Leuven1 papers (2013–2013)Antonio Jimeno · University of Colorado Denver1 papers (2013–2013)N.S. Reed · KU Leuven1 papers (2013–2013)Jack Power · University of Technology Sydney1 papers (2023–2023)Laure Favier · Hôpital Européen Georges-Pompidou1 papers (2013–2013)M.H.N. Tattersall · National Health Laboratory Service1 papers (2014–2014)John Green · KU Leuven1 papers (2013–2013)Phillip Parente · Monash Medical Centre1 papers (2014–2014)Giuseppe Colloca · 1 papers (2014–2014)H. Wildiers · KU Leuven1 papers (2014–2014)Afaf Girgis · Sydney South West Area Health Service1 papers (2014–2014)